Chronic obstructive pulmonary disease among adults--United States, 2011
- PMID: 23169314
Chronic obstructive pulmonary disease among adults--United States, 2011
Abstract
Chronic obstructive pulmonary disease (COPD) is a group of progressive, debilitating respiratory conditions, including emphysema and chronic bronchitis, characterized by difficulty breathing, lung airflow limitations, cough, and other symptoms. COPD often is associated with a history of cigarette smoking and is the primary contributor to mortality caused by chronic lower respiratory diseases, which became the third leading cause of death in the United States in 2008. Despite this substantial disease burden, state-level data on the prevalence of COPD and associated health-care resource use in the United States have not been available for all states. To assess the state-level prevalence of COPD among adults, the impact of COPD on their quality of life, and the use of health-care resources by those with COPD, CDC analyzed data from the 2011 Behavioral Risk Factor Surveillance System (BRFSS). Among BRFSS respondents in all 50 states, the District of Columbia (DC), and Puerto Rico, 6.3% reported having been told by a physician or other health professional that they had COPD. In addition to the screening question asked of all respondents, 21 states, DC, and Puerto Rico elected to include an optional COPD module. Among persons who reported having COPD and completed the optional module, 76.0% reported that they had been given a diagnostic breathing test, 64.2% felt that shortness of breath impaired their quality of life, and 55.6% were taking at least one daily medication for their COPD. Approximately 43.2% of them reported visiting a physician for COPD-related symptoms in the previous 12 months, and 17.7% had either visited an emergency department or been admitted to a hospital for their COPD in the previous 12 months. Continued surveillance for COPD, particularly at state and local levels, is critical to 1) identify communities that likely will benefit most from awareness and outreach campaigns and 2) evaluate the effectiveness of public health efforts related to the prevention, treatment, and control of the disease.
Similar articles
-
Chronic obstructive pulmonary disease and associated health-care resource use - North Carolina, 2007 and 2009.MMWR Morb Mortal Wkly Rep. 2012 Mar 2;61(8):143-6. MMWR Morb Mortal Wkly Rep. 2012. PMID: 22377845
-
State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.MMWR Surveill Summ. 2003 Aug 22;52(8):1-80. MMWR Surveill Summ. 2003. PMID: 14532868
-
Surveillance of certain health behaviors and conditions among states and selected local areas --- Behavioral Risk Factor Surveillance System, United States, 2009.MMWR Surveill Summ. 2011 Aug 19;60(9):1-250. MMWR Surveill Summ. 2011. PMID: 21849967
-
Chronic obstructive pulmonary disease: definition and epidemiology.Respir Care. 2003 Dec;48(12):1185-91; discussion 1191-3. Respir Care. 2003. PMID: 14651759 Review.
-
Epidemiology and global impact of chronic obstructive pulmonary disease.Semin Respir Crit Care Med. 2005 Apr;26(2):204-10. doi: 10.1055/s-2005-869539. Semin Respir Crit Care Med. 2005. PMID: 16088437 Review.
Cited by
-
Smoking-Attributable Health Care Expenditures for US Adults With Chronic Lower Respiratory Disease.JAMA Netw Open. 2024 May 1;7(5):e2413869. doi: 10.1001/jamanetworkopen.2024.13869. JAMA Netw Open. 2024. PMID: 38814643 Free PMC article.
-
Barriers to Pulmonary Rehabilitation.Respir Care. 2024 May 28;69(6):713-723. doi: 10.4187/respcare.11656. Respir Care. 2024. PMID: 38806224
-
Disease Burden and Health-Related Quality of Life (HRQoL) of Chronic Obstructive Pulmonary Disease (COPD) in the US - Evidence from the Medical Expenditure Panel Survey (MEPS) from 2016-2019.Int J Chron Obstruct Pulmon Dis. 2024 May 13;19:1033-1046. doi: 10.2147/COPD.S446696. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38765766 Free PMC article.
-
Inflammation mediates the association between furan exposure and the prevalence and mortality of chronic obstructive pulmonary disease: National Health and Nutrition Examination Survey 2013-2018.BMC Public Health. 2024 Apr 15;24(1):1046. doi: 10.1186/s12889-024-18442-9. BMC Public Health. 2024. PMID: 38622557 Free PMC article.
-
Chronic obstructive pulmonary disease is an independent risk factor for increased opioid use in total hip arthroplasty: A retrospective PearlDiver study.J Orthop. 2023 Sep 22;46:95-101. doi: 10.1016/j.jor.2023.09.010. eCollection 2023 Dec. J Orthop. 2023. PMID: 37969229
MeSH terms
LinkOut - more resources
Full Text Sources
Medical

